【阿尔茨海默病创新药在乐城实现中国内地首用】 2月21日,得益于“先行先试”政策,创新药物donanemab在中国内地率先落地上海交通大学医学院附属瑞金医院海南医院,用于治疗处在疾病轻度认知障碍阶段或轻度痴呆阶段的阿尔茨海默病患者,为国内患者带来新的用药选择。

金融界
23 Feb
2月21日,得益于“先行先试”政策,创新药物donanemab在中国内地率先落地上海交通大学医学院附属瑞金医院海南医院,用于治疗处在疾病轻度认知障碍阶段或轻度痴呆阶段的阿尔茨海默病患者,为国内患者带来新的用药选择。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10